Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary osteosarcoma: case report and molecular analysis.

A D Chapman1, S C Pritchard, W W Yap

  • 1Department of Pathology, University of Aberdeen, Aberdeen, Scotland, United Kingdom.

Cancer
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

ESMO open·2023
Same author

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Primary pulmonary osteosarcoma, a rare cancer, was investigated in a new patient using advanced techniques. Genetic analysis revealed significant aberrations, offering insights into this aggressive tumor's unique characteristics and potential treatment resistance.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Primary pulmonary osteosarcoma is an exceptionally rare cancer with a high mortality rate, with only 12 prior cases documented.
  • This study details the investigation of a newly diagnosed case of primary pulmonary osteosarcoma.

Observation:

  • A 37-year-old female patient with primary pulmonary osteosarcoma underwent comprehensive diagnostic evaluation.
  • Methods included routine histology, immunohistochemistry for tumor markers, comparative genomic hybridization (CGH) for genomic alterations, and histochemistry for alkaline phosphatase activity.

Findings:

  • Immunohistochemistry revealed distinct expression patterns, notably high BCL-2 and cyclin D overexpression.
  • CGH analysis identified a higher degree of genetic aberrations compared to skeletal osteosarcoma.

Related Experiment Videos

  • The tumor exhibited genetic similarities to extraskeletal osteosarcoma.

    • Implications:

    • The identified genetic aberrations may explain the unique tumor phenotype and chemoresistance.
    • Understanding these genomic alterations is crucial for developing targeted therapies for pulmonary osteosarcoma.